Oncology & Cancer

Cancer-seeking 'smart bombs' target kidney cancer cells

Researchers are halting kidney cancer with a novel form of radioimmunotherapy that zeroes in on antigens associated with renal cell carcinoma. Patients with progressive kidney cancer receiving up to three doses of the therapy ...

Other

The case for maintaining current regulations on I-131 therapy

Two articles in the June issue of The Journal of Nuclear Medicine make a case for maintaining current U.S. Nuclear Regulatory Commission (NRC) regulations on the release of patients who undergo radioactive iodine treatments ...

page 21 from 24